CHTP 1.2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CHTP 1.2, covering 2019-03-06 to 2019-03-06. Get the full timeline:
Most recent: Clinical Trial Update: Reduced Exposure Study Using the CHTP 1.2 With 5 Days in a Confinement Setting Followed by 85 Days in an Ambulatory Setting. [NA]